These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37039180)

  • 21. Rise of the phoenix: Mucormycosis in COVID-19 times.
    Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
    Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India.
    Aranjani JM; Manuel A; Abdul Razack HI; Mathew ST
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009921. PubMed ID: 34793455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting clinical outcome in COVID-associated rhino-orbito-cerebral mucormycosis (CAROM) patients-An ambispective, single-arm, observational study.
    Singh A; Goel G; Khan M; Kanodia A; Sikka K; Thakar A
    Am J Otolaryngol; 2023; 44(6):103975. PubMed ID: 37478538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
    Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucormycosis and COVID-19: An epidemic within a pandemic in India.
    Selarka L; Sharma S; Saini D; Sharma S; Batra A; Waghmare VT; Dileep P; Patel S; Shah M; Parikh T; Darji P; Patel A; Goswami G; Shah A; Shah S; Lathiya H; Shah M; Sharma P; Chopra S; Gupta A; Jain N; Khan E; Sharma VK; Sharma AK; Chan ACY; Ong JJY
    Mycoses; 2021 Oct; 64(10):1253-1260. PubMed ID: 34255907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical-epidemiological Profile of Coronavirus Disease 19 Associated Mucomycosis (CAM) and Relation with Zinc and Iron Levels.
    Karoli R; Kulshreshtha MR; Gupta N; Singh M; Singh V; Shakya S
    J Assoc Physicians India; 2022 Feb; 70(2):11-12. PubMed ID: 35436818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience on rhino-orbital mucormycosis from a tertiary care hospital in the first wave of COVID-19: An Indian perspective.
    Saluja G; Bhari A; Pushker N; Agrawal S; Meel R; Thakar A; Xess I; Khandelwal A; Narwal A; Bajaj MS
    Med J Armed Forces India; 2022 Apr; 79(Suppl 1):S94-S101. PubMed ID: 35400798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucormycosis and Covid-19 : Risk Factors, Clinical Presentation and Outcome in a Tertiary Care Centre in North India.
    A GA; Ashraf H; HaiderMehdi HS
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
    Singh AK; Singh R; Joshi SR; Misra A
    Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-Covid Cerebral Mucormycosis, Varied Presentations and Surgical Strategies of a Newer Epidemic: An Institutional Experience.
    Vijayasekhar MV; Nagappa V; Swaroop KH; Mithun G; Achuith E; Varaprasad KS
    Neurol India; 2022; 70(3):1052-1056. PubMed ID: 35864638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucormycosis in COVID-19 patients.
    Sundaram N; Bhende T; Yashwant R; Jadhav S; Jain A
    Indian J Ophthalmol; 2021 Dec; 69(12):3728-3733. PubMed ID: 34827032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Cross-Sectional Study of First Hundred Cases of Rhino-Orbital-Cerebral Mucormycosis Admitted at a Tertiary Care Hospital.
    Poswal L; Bunkar GL; Sharma R; Jain A; Samar N; Mathur N; Singh M; Kaushik PB
    Indian J Community Med; 2022; 47(3):433-436. PubMed ID: 36438531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orbital magnetic resonance imaging profile and clinicoradiological correlation in COVID-19-associated rhino-orbital-cerebral mucormycosis: A single-center study of 270 patients from North India.
    Hada M; Gupta P; Bagarhatta M; Tripathy K; Harsh A; Khilnani K; Mendiratta K; Agarwal S; Chouhan JK; Bhandari S
    Indian J Ophthalmol; 2022 Feb; 70(2):641-648. PubMed ID: 35086254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case Report: Rhino-orbital Mucormycosis Related to COVID-19: A Case Series Exploring Risk Factors.
    Aggarwal SK; Kaur U; Talda D; Pandey A; Jaiswal S; Kanakan A; Singh A; Chakrabarti SS
    Am J Trop Med Hyg; 2021 Dec; 106(2):566-570. PubMed ID: 34902834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome.
    Sahu M; Shah M; Mallela VR; Kola VR; Boorugu HK; Punjani AAR; Kumar RV; Kumar S; Manusrut M; Kumar SCR; Rathod R; Babu DM; Gonuguntla HK; Yedlapati GK; Mallu GR; Reddy YS; Reddy VV; Alwala S; Bongu VK; Kamalesh A; Kumar RNK; Jaishetwar GS; Bagapally RS; Srinivas JS; Balasubramaniam A; Rajagopalan BK; Pullikanti B; Prakasham SP; Nimmala P; Nagaraju B; Sahoo PR;
    Infection; 2023 Apr; 51(2):407-416. PubMed ID: 35922704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study.
    Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S
    Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.